
--- Page 1 ---
Ics-0-3 Ca^cioms, n^f1+nsHNg duct,Nos 85oo/3 S,s: but, Nus C50-9 3/f iw page 1 / 2  Department of Cancer Pathology copy No. Date: Examination: Intraoperative examination Internal invoice No. Cost of diagnostic procedure Examination No.: Patient: XXX PeseL: XXX Age: Gender: F Material: 1. Partial organ resection -- Lesion in the right breast -- outer upper quad. Unit in charge:  Physician in charge: Material collected on Material received on Expected time of examination: 20 minutes (from receipt of material) Clinical diagnosis: Suspected breast cancer (PCI - cellulae atypicae, MMR and clinically- ca). Please review the tumour and margins.  Examination performed on: Result of intraoperative examination: Carcinoma invasivum Compliance validated by. Examination performed on: Macroscopic description: Fragment of the right breast sized 8 x 7 x 4 cm with a 5 x 2 cm skin flap, marked typically, no RTG. Tumour sized 2.5 x 1.5 x 1 cm in the cross section. Margins: 0.8 cm to the base; 1.3 cm to the front surface; 2.5 cm to the sternum; 3 cm to the axilla; 4 cm to the shoulder; 1.3 cm to the lower boundary.. Preliminary result: Carcinoma ductale invasivum NHG2 (3 + 2 + 2/9 mitoses/10 HPF - visual area 0.55 mm). Carcinoma ductale in situ, solid type with high nuclear atypia with comedo necrosis and calcifications. Final diagnosis after all material are analysed. Compliance validated by:. Examination performed on: UUID:E1907A10-2078-41F1-888B-24D5B5518D05 TCGA-D8-A13G-01A-PR Results of immunohistochemical examination: Redacted No estrogen receptors found in neoplastic cell nuclei. No progesterone receptors found in neoplastic cell nuclei. HER2 protein stained with HercepTestTM by DAKO. Score = 2+ , FIsH verification recommended. Compliance validated by: DISQUALHIED

--- Page 2 ---
Examination: Histopathological examinationpage 2 / 2 Examination No.: Patient: XXX PESEL: XXX Gender: F Examination performed on: Microscopic description Carcinoma ductale invasivum NGH2 (3 + 2 + 2/9 mitoses/ 10 HPF/ visual area diameter 0.55 mm). Carcinoma ductale in situ, solid type with high nuclear atypia with comedo necrosis and calcifications. Margins of normal tissues as in the macroscopic description. Reactivo lymphocytaria peritumoralis. Additionally, mastopathia fibrosa et cystica. Histopathological diagnosis:e Carcinoma ductale invasivum et in situ mammae dextrae G2, pT2. invasive ductal carcinoma of the right breast Compliance validated by: Examination performed on. Results of immunohistochemical examination: RESULT OF HER2/neu GENE AMPLIFiCATION with the FISH method by Path Vysion HER2 DNA Probe Kit FINAL RESULT: HER-2 gene AMPLIFICATION NOt FOUND. Anna Malicka Compliance validated by: Examination performed on:. Supplementary test:. Including the examination No. Carcinoma ductale invasivum et in situ mammae dextrae. (NHG2, pT2, pN0) Compliance validated by